The Work We Fund

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

GAP2 The Advanced Prostate Cancer Imaging Initiative - AUS

Movember Funding to Date

Global funding AUD equivalent 4,901,870

What we seek to achieve

To improve imaging techniques for men with advanced prostate cancer. By better determining where prostate cancer has spread and what sort of cells make up this spread, treatments can be better tailored for an individual.

Country
Australia
Implemented by
The Movember Foundation
Project start date
January 2014
Project Status
Completed July 2016

About the project

The GAP2 Advanced Prostate Cancer Imaging Initiative brings together top researchers from around the world to collaborate and share knowledge. This groundbreaking effort aims to improve how doctors detect and treat prostate cancer that has spread to other parts of the body.

If doctors can accurately identify where prostate cancer has spread (known as metastatic tumours), they can tailor treatment more precisely to each man’s needs.

GAP2 is made up of four research projects, each focused on a new radioactive PET imaging tracer. These tracers help detect the spread of cancer cells in men with advanced prostate cancer.

Since 2013, Movember has invested nearly $5 million AUD into GAP2, leading to several key outcomes:

Development of Fluciclovine: 
•    The first PET imaging tracer approved by the FDA in 2016, Fluciclovine helps detect prostate cancer in men with rising PSA levels after their initial treatment.

68Ga-PSMA Clinical Trial: 
•    This trial showed that the 68Ga-PSMA tracer could detect twice as many prostate cancer tumours compared to the 11C-Choline tracer.

Creation of 18F-DCFPyL: 
•    This new imaging tracer was commercialised and tested in two large clinical trials. In 2022, it received FDA approval for detecting prostate cancer tumours both at initial diagnosis and when the disease returns.

Ongoing Research: 
•    The final project, which compares two tracers (18F-FDHT vs PSMA), is expected to deliver results by 2025.

These advancements are helping doctors around the world better diagnose and treat prostate cancer, improving outcomes for men with the disease.

(Local investment AUD 1,035,499)

Prostate Cancer Research Alliance

The Program will fund research that leverages Australia's existing strengths in prostate cancer biomedical research to deliver outcomes that can be translated into clinical practice within the next 5 to 7 years.

Find out more
Australia
AUD 12,150,000
USA - Mass market, multi-platform public media documentary series & campaign

This project uses a mass market, multi dimensional campaigns to shift populations understanding, attitudes and intentions and ultimately improve health outcomes on a large scale. Focusing on Youth Mental Health we will be working in partnership with PBS to deliver a documentary series supported with educational, digital and in person elements delivered across the USA.

Find out more
United States
USD 2,400,000
Ironman Registry - ZAF

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
South Africa
Global Funding AUD equivalent 18,905,25
Ironman Registry - ESP

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Spain
Global Funding AUD equivalent 18,905,25
Ironman Registry - IRL

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Ireland
Global Funding AUD equivalent 18,905,25
Ironman Registry - CHE

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Switzerland
Global Funding AUD equivalent 18,905,25
Ironman Registry - SWE

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Sweden
Global Funding AUD equivalent 18,905,25
Ironman Registry - USA

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United States
Global Funding AUD equivalent 18,905,25
Ironman Registry - GBR

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United Kingdom
Global Funding AUD equivalent 18,905,25
Ironman Registry - CAN

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Canada
Global Funding AUD equivalent 18,905,25
Ironman Registry - AUS

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Australia
Global Funding AUD equivalent 18,905,25
Movember – Distinguished Gentleman’s Ride Clinician Scientist Award - 2017

Clinician Scientist Awards aim to support outstanding, clinically qualified professionals who have gained a PhD in health research, to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer.

Find out more
Australia
-
TrueNTH Global Registry - AUS

Established in 2017 and operating across 17 countries, the TrueNTH Global Registry is an international project that aims to improve the physical and mental health of men with prostate cancer. Clinicians and hospitals contributing data to TrueNTH Global Registry receive regular, risk-adjusted reports on their patients’ health outcomes as compared to other clinicians and hospitals globally. This will support improvement in clinical practice and patient outcomes over time.

Find out more
Australia
Global funding AUD equivalent 20,336,828
Canadian Men's Health & Wellbeing Innovation Challenge

To support the implementation of outside the box proof of concept ideas that disrupt long held assumptions/myths about men and their health which will encourage doing things differently and ultimately lead to improved health outcomes.

Find out more
Canada
CAD 1,923,149
Prostate Cancer Outcomes - Registry Australia and New Zealand

The Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ) is a clinical quality registry collecting data on the diagnosis, clinical care and outcomes for men living with prostate cancer across Australia and New Zealand.

Find out more
Australia
Global funding AUD equivalent 22,397,860
Nuts & Bolts

Nuts & Bolts is a website, optimised for mobile devices, that aims to bring resources to men who are facing a diagnosis of early stage testicular cancer. Using the principles of user-centred design, we have created a resource that delivers curated, relevant, and timely information to help men navigate their testicular cancer journey, from diagnosis and treatment to life after treatment.

Find out more
Australia
AUD 1,180,594
>
Page 1 of 33